Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Pharvaris NV (PHVS)

Pharvaris NV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PHVS
DateTimeSourceHeadlineSymbolCompany
02/12/202421:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
13/11/202421:12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHVSPharvaris NV
13/11/202421:10GlobeNewswire Inc.Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business UpdatesNASDAQ:PHVSPharvaris NV
12/11/202411:50GlobeNewswire Inc.Pharvaris to Participate in the Guggenheim Healthcare Innovation ConferenceNASDAQ:PHVSPharvaris NV
31/10/202420:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
24/10/202420:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
24/10/202412:00GlobeNewswire Inc.Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific MeetingNASDAQ:PHVSPharvaris NV
16/10/202410:50GlobeNewswire Inc.Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific MeetingsNASDAQ:PHVSPharvaris NV
15/10/202410:50GlobeNewswire Inc.Pharvaris to Host Virtual Investor Event on October 23, 2024NASDAQ:PHVSPharvaris NV
03/10/202410:50GlobeNewswire Inc.Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership WorkshopNASDAQ:PHVSPharvaris NV
25/09/202410:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHVSPharvaris NV
23/09/202410:51Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHVSPharvaris NV
20/09/202420:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
19/09/202422:45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
19/09/202422:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
19/09/202420:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
16/09/202420:46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
05/09/202410:51Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHVSPharvaris NV
05/09/202410:50GlobeNewswire Inc.Pharvaris Provides Business Update and Expands Development Program for DeucrictibantNASDAQ:PHVSPharvaris NV
05/09/202410:49GlobeNewswire Inc.Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024NASDAQ:PHVSPharvaris NV
05/09/202410:48GlobeNewswire Inc.Pharvaris Presents Data at the Bradykinin Symposium 2024NASDAQ:PHVSPharvaris NV
28/08/202410:50GlobeNewswire Inc.Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin SymposiumNASDAQ:PHVSPharvaris NV
14/08/202410:51Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHVSPharvaris NV
14/08/202410:50GlobeNewswire Inc.Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:PHVSPharvaris NV
11/06/202410:52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHVSPharvaris NV
11/06/202410:50GlobeNewswire Inc.Pharvaris Announces Annual Meeting of ShareholdersNASDAQ:PHVSPharvaris NV
04/06/202420:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHVSPharvaris NV
04/06/202410:50GlobeNewswire Inc.Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent CongressesNASDAQ:PHVSPharvaris NV
24/05/202421:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
22/05/202421:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
 Showing the most relevant articles for your search:NASDAQ:PHVS